BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

637 related articles for article (PubMed ID: 16914519)

  • 1. Valosin-containing protein (p97) is a regulator of endoplasmic reticulum stress and of the degradation of N-end rule and ubiquitin-fusion degradation pathway substrates in mammalian cells.
    Wójcik C; Rowicka M; Kudlicki A; Nowis D; McConnell E; Kujawa M; DeMartino GN
    Mol Biol Cell; 2006 Nov; 17(11):4606-18. PubMed ID: 16914519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Destabilization of the VCP-Ufd1-Npl4 complex is associated with decreased levels of ERAD substrates.
    Nowis D; McConnell E; Wójcik C
    Exp Cell Res; 2006 Sep; 312(15):2921-32. PubMed ID: 16822501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of SVIP as an endogenous inhibitor of endoplasmic reticulum-associated degradation.
    Ballar P; Zhong Y; Nagahama M; Tagaya M; Shen Y; Fang S
    J Biol Chem; 2007 Nov; 282(47):33908-14. PubMed ID: 17872946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AAA ATPase p97/valosin-containing protein interacts with gp78, a ubiquitin ligase for endoplasmic reticulum-associated degradation.
    Zhong X; Shen Y; Ballar P; Apostolou A; Agami R; Fang S
    J Biol Chem; 2004 Oct; 279(44):45676-84. PubMed ID: 15331598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between salt-inducible kinase 2 (SIK2) and p97/valosin-containing protein (VCP) regulates endoplasmic reticulum (ER)-associated protein degradation in mammalian cells.
    Yang FC; Lin YH; Chen WH; Huang JY; Chang HY; Su SH; Wang HT; Chiang CY; Hsu PH; Tsai MD; Tan BC; Lee SC
    J Biol Chem; 2013 Nov; 288(47):33861-33872. PubMed ID: 24129571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tissue-specific Rep8/UBXD6 tethers p97 to the endoplasmic reticulum membrane for degradation of misfolded proteins.
    Madsen L; Kriegenburg F; Vala A; Best D; Prag S; Hofmann K; Seeger M; Adams IR; Hartmann-Petersen R
    PLoS One; 2011; 6(9):e25061. PubMed ID: 21949850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A proteasomal ATPase contributes to dislocation of endoplasmic reticulum-associated degradation (ERAD) substrates.
    Lipson C; Alalouf G; Bajorek M; Rabinovich E; Atir-Lande A; Glickman M; Bar-Nun S
    J Biol Chem; 2008 Mar; 283(11):7166-75. PubMed ID: 18174173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoplasmic reticulum vacuolization and valosin-containing protein relocalization result from simultaneous hsp90 inhibition by geldanamycin and proteasome inhibition by velcade.
    Mimnaugh EG; Xu W; Vos M; Yuan X; Neckers L
    Mol Cancer Res; 2006 Sep; 4(9):667-81. PubMed ID: 16966435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of ER-associated degradation via p97/VCP-interacting motif.
    Ballar P; Fang S
    Biochem Soc Trans; 2008 Oct; 36(Pt 5):818-22. PubMed ID: 18793143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of a novel p97/valosin-containing protein-interacting motif of gp78 in endoplasmic reticulum-associated degradation.
    Ballar P; Shen Y; Yang H; Fang S
    J Biol Chem; 2006 Nov; 281(46):35359-68. PubMed ID: 16987818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRSK2 is a valosin-containing protein (VCP)-interacting protein that affects VCP functioning in endoplasmic reticulum-associated degradation.
    Wang Y; Wan B; Zhou J; Li R; Yu L
    Biotechnol Lett; 2013 Dec; 35(12):1983-9. PubMed ID: 23907667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA interference of valosin-containing protein (VCP/p97) reveals multiple cellular roles linked to ubiquitin/proteasome-dependent proteolysis.
    Wójcik C; Yano M; DeMartino GN
    J Cell Sci; 2004 Jan; 117(Pt 2):281-92. PubMed ID: 14657277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and mechanistic insights into the arginine/lysine-rich peptide motifs that interact with P97/VCP.
    Liu S; Fu QS; Zhao J; Hu HY
    Biochim Biophys Acta; 2013 Dec; 1834(12):2672-8. PubMed ID: 24100225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional ATPase activity of p97/valosin-containing protein (VCP) is required for the quality control of endoplasmic reticulum in neuronally differentiated mammalian PC12 cells.
    Kobayashi T; Tanaka K; Inoue K; Kakizuka A
    J Biol Chem; 2002 Dec; 277(49):47358-65. PubMed ID: 12351637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ataxin-3 binds VCP/p97 and regulates retrotranslocation of ERAD substrates.
    Zhong X; Pittman RN
    Hum Mol Genet; 2006 Aug; 15(16):2409-20. PubMed ID: 16822850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inclusion body myopathy-associated mutations in p97/VCP impair endoplasmic reticulum-associated degradation.
    Weihl CC; Dalal S; Pestronk A; Hanson PI
    Hum Mol Genet; 2006 Jan; 15(2):189-99. PubMed ID: 16321991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential actions of the AAA-ATPase valosin-containing protein (VCP)/p97 and the proteasome 19 S regulatory particle in sterol-accelerated, endoplasmic reticulum (ER)-associated degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
    Morris LL; Hartman IZ; Jun DJ; Seemann J; DeBose-Boyd RA
    J Biol Chem; 2014 Jul; 289(27):19053-66. PubMed ID: 24860107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different p97/VCP complexes function in retrotranslocation step of mammalian ER-associated degradation (ERAD).
    Ballar P; Pabuccuoglu A; Kose FA
    Int J Biochem Cell Biol; 2011 Apr; 43(4):613-21. PubMed ID: 21199683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel function of VCP (valosin-containing protein; p97) in the control of N-glycosylation of proteins in the endoplasmic reticulum.
    Lass A; McConnell E; Nowis D; Mechref Y; Kang P; Novotny MV; Wójcik C
    Arch Biochem Biophys; 2007 Jun; 462(1):62-73. PubMed ID: 17493577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective inhibition of endoplasmic reticulum-associated degradation rescues DeltaF508-cystic fibrosis transmembrane regulator and suppresses interleukin-8 levels: therapeutic implications.
    Vij N; Fang S; Zeitlin PL
    J Biol Chem; 2006 Jun; 281(25):17369-17378. PubMed ID: 16621797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.